PINGSENG Healthcare (Kunshan) Inc. (hereinafter referred to as "PINGSENG") is a high-tech enterprise specialized in advanced molecular imaging devices. Its product portfolio spans pre-clinical, clinical, optical and veterinary imaging. The business has its wholly-owned R&D, Production, Marketing, Sales and Services.


PINGSENG, with a registered capital of 130 million Yuan, has a highly talented R&D team and has developed an advanced quality management system. It has fully independent intellectual property rights and unique manufacturing processes in the field of molecular imaging. It encourages scientific and technological innovation, and strives to become the most innovative enterprise in China. PINGSENG aims to become the world's leading manufacturer in the field of molecular imaging.

The pre-clinical imaging systems (PET/CT and CT) represent the best of its kind developed in China, and have begun to expand in the international market. The core component of the X-ray imaging devices (CsI conversion screen) has also been developed by PINGSENG and exported to Switzerland, Ukraine and other European countries, and is gradually entering the North America market. PINGSENG strives to bring the most advanced medical technology to general public. It is committed to providing high-end specialized medical imaging devices with lowest possible cost. The clinical product – the world's first human head/neck PET/CT, will soon formally enter the clinic field to benefit the public. The moral in PINGSENG is "Technical Innovation and Supreme Quality"; we are well on track to convert scientific research and technical innovation to commercial products.

PINGSENG always adheres to the intention of servicing customers as the first principle. It provides customers with reliable products, professional technical guidance and as well as comprehensive after-sale services. The company pays attention to the combination of production, teaching and medical research. It boasts active close collaboration with major hospitals, universities and enterprises to explore and broaden pre-clinical, clinical, optical and research applications of its products.